Skip to main content

Carbidopa and Levodopa

NDC 59651-456 · Aurobindo Pharma Limited

Generic nameCarbidopa and Levodopa

Dosage formTABLET

RouteORAL

Active ingredient(s)CARBIDOPA, LEVODOPA

Strength10; 100 mg/1; mg/1

Pharmacologic classAmino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]

Marketing categoryANDA

Packages

59651-456-01 — 100 TABLET in 1 BOTTLE (59651-456-01)

59651-456-05 — 500 TABLET in 1 BOTTLE (59651-456-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50268-202 — Carbidopa and Levodopa, 51079-923 — carbidopa and levodopa, 51079-978 — carbidopa and levodopa, 52817-390 — carbidopa and levodopa, 52817-391 — carbidopa and levodopa, 52817-392 — carbidopa and levodopa, 53401-020 — Carbidopa and Levodopa, 55154-0192 — Carbidopa and Levodopa, 55154-2643 — Carbidopa and Levodopa, 59651-146 — Carbidopa, 59651-457 — Carbidopa and Levodopa, 59651-458 — Carbidopa and Levodopa, 60219-2033 — CARBIDOPA and LEVODOPA, 60219-2034 — CARBIDOPA and LEVODOPA, 60687-661 — Carbidopa and Levodopa, 60687-836 — Carbidopa and Levodopa, 62332-332 — Carbidopa and Levodopa, 62332-333 — Carbidopa and Levodopa, 62332-795 — carbidopa, levodopa and entacapone, 62332-796 — carbidopa, levodopa and entacapone, +147 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels